Developing the Escherichia coli Platform for Efficient Glycosylation of Steviol Glycosides through Metabolic Engineering
ACS Synthetic Biology · 2026
DOI: 10.1021/acssynbio.6c00527 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Yiming Yuan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of …. Hauptthemen laut MEDLINE: Escherichia coli, Metabolic Engineering, Diterpenes, Kaurane, Glycosides. Die Arbeit nennt 91 Literaturangaben. Gefördert von: Department of Science and Technology of Sichuan Province, Chengdu Municipal Science and Technology Program.
Abstract (Originalsprache)
Rare steviol glycosides (SGs), characterized by superior sensory profiles and promising bioactivities, are high-intensity sweeteners derived from Stevia rebaudiana. Their intrinsically low abundance limits extraction yields, while in vitro bioconversion is limited by the availability of UDP-glucose (UDPG). Here, an Escherichia coli chassis was reprogrammed to achieve an intracellular UDPG content of 11.72 μmol/g CDW, 2.19-fold that of BL21(DE3), by enhancing pyrimidine nucleotide synthesis, blocking competing pathways, redirecting carbon flux, and optimizing the expression of key genes. Coupled with a UGT−SuSy system, the platform enabled in vitro conversion of Reb A into rare derivativesReb L2, Reb D, Reb D2, Reb M, Reb M2, and Reb M8without exogenous UDPG, with 1.6- to 129-fold higher conversion efficiencies than the wild type. Cultured in a 5 L bioreactor, harvested cells yielded 108.57 g/L Reb L2 and 111.99 g/L Reb D via in vitro whole-cell biotransformation. This platform provides a route for rare SG production and a versatile foundation for the glycodiversification of natural products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Provincial Key Laboratory of Biotechnology, College of Life Sciences Northwest University , 229 Taibai North Road, Xi'an, Sha…
- Sichuan Ingia Biosynthetic Co., Ltd., Chengdu610200, China.
- State Key Laboratory of Bioreactor Engineering, School of Biotechnology, East China University of Science and Technology, Shanghai200237, China.
- CAS-Key Laboratory of Synthetic Biology, CAS Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, Shanghai200032, China.
- University of Chinese Academy of Sciences, Beijing100039, China.
- Faculty of Materials and Chemical Engineering, Yibin University, Yibin644000, China.
ORCID-Profile: Shiwei Wang, Yong Wang, Wei Li
Förderung
- Department of Science and Technology of Sichuan Province
- Chengdu Municipal Science and Technology Program
Zitieren
APA
Yuan, Y., Wang, S., Pei, L., Xu, X., Pan, Y., Du, J., Liu, P., Liu, C., He, N., Hua, J., Wang, Y., & Li, W. (2026). Developing the Escherichia coli Platform for Efficient Glycosylation of Steviol Glycosides through Metabolic Engineering. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00527
Vancouver
Yuan Y, Wang S, Pei L, Xu X, Pan Y, Du J, et al. Developing the Escherichia coli Platform for Efficient Glycosylation of Steviol Glycosides through Metabolic Engineering. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00527
BibTeX
@article{Yuan2026,
author = {Yuan, Yiming and Wang, Shiwei and Pei, Liang and Xu, Xinyu and Pan, Yue and Du, Jingping and Liu, Ping and Liu, Chao and He, Ni and Hua, Jun and Wang, Yong and Li, Wei},
title = {Developing the Escherichia coli Platform for Efficient Glycosylation of Steviol Glycosides through Metabolic Engineering},
journal = {ACS Synthetic Biology},
year = {2026},
doi = {10.1021/acssynbio.6c00527}
}
EUVIMED